KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio (2021 - 2025)

Recursion Pharmaceuticals (RXRX) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.05 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 3.93% year-over-year to 0.05, compared with a TTM value of 0.05 through Dec 2025, down 3.93%, and an annual FY2025 reading of 0.05, down 8.7% over the prior year.
  • Asset Utilization Ratio was 0.05 for Q4 2025 at Recursion Pharmaceuticals, up from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.09 in Q3 2024 and bottomed at 0.02 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.05 recorded in 2025.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 278.38% in 2022, then plummeted 62.73% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.02 in 2021, then surged by 278.38% to 0.06 in 2022, then rose by 14.34% to 0.07 in 2023, then decreased by 22.05% to 0.05 in 2024, then dropped by 3.93% to 0.05 in 2025.
  • Business Quant data shows Asset Utilization Ratio for RXRX at 0.05 in Q4 2025, 0.03 in Q3 2025, and 0.05 in Q2 2025.